Latest Profitability News

Strata Minerals has shifted from broad exploration to a Zelica-centred Western Australian gold strategy, pairing strong drilling results with a proposed capital-light mining pathway funded by BML Ventures. The opportunity is growing, but the company remains loss-making and warns that further funding may be required to continue as a going concern.

Prairie Lithium has moved its Saskatchewan project closer to commissioning, with Pad #1 construction advancing and Hydro Lithium agreeing to buy all Phase 1 output. The progress came alongside a A$3.46 million FY2026 loss, further equity issuance and a year-end cash balance of A$5.85 million.

Evion Group has moved its flagship Maniry graphite project into the development stage and secured a binding German offtake terms sheet, but its FY2026 accounts carry a material going concern warning. The company also faces an unpaid A$730,000 placement shortfall as it funds graphite, fluorspar and downstream expansion plans.

Ziller Global Fund Active ETF reported a $1.77 million comprehensive loss for the year ended 30 June 2026, despite net assets rising to $10.9 million. The fund’s ASX debut, $10.2 million of applications and enlarged distribution came alongside a sharp investment loss.

Global X FANG+ ETF reported a sharp decline in annual profit, while its net asset value fell by more than 10% after 30 June as underlying technology stocks weakened. The audited fund still grew net assets to AUD1.606 billion and declared a 235.84 cents-per-unit distribution.

Global X China Tech ETF reported an AUD15.727 million profit for the year ended 30 June 2026, powered by gains in listed Chinese technology investments. But the fund disclosed that its net asset value has since fallen by more than 10%, leaving the audited result looking increasingly historical.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.

Global X S&P/ASX 200 Covered Call Complex ETF reported a sharp lift in annual profit as realised investment gains strengthened, while net assets passed $100 million. The fund declared 23.80 cents per unit for its June distribution, but its returns remain exposed to equity prices, options and a suspended holding valued at zero.

Global X Artificial Intelligence Infrastructure ETF (ASX:AINF) reported a $25.291 million profit for its first full financial year, driven overwhelmingly by investment gains. Net assets climbed to $169.603 million after almost $147.2 million of new unit applications, while the fund paid a 61.64 cents per unit distribution.

Global X Battery Tech & Lithium ETF delivered a sharply higher profit for the year ended 30 June 2026, driven by large fair-value gains across its listed equity portfolio. But the fund says its net asset value has since fallen by more than 10% as underlying battery and lithium investments weakened.

PIMCO Short Term Active Yield Fund grew net assets nearly eightfold to A$239.8 million in the year to 30 June 2026, as its ASX-listed EARN ETF class attracted new capital. All reported unit classes outperformed the fund’s cash-rate benchmark, although the ETF’s 3.11% return covers only nine months.

Bremworth has restored internal yarn production, cut costs and improved its inventory profile, but FY26 still ended with an NZ$11.4 million loss. The company now enters FY27 under new ownership and board dynamics, with positive operating cash flow still to be achieved.